Press Releases
Ceapro Inc. Provides Update on Development of an Inhalable Therapeutic for COVID-19
Ceapro Inc. Announces Publication of Positive Results from Study Evaluating Avenanthramides in Exercise-Induced Inflammation
Ceapro Announces Results of 2020 Shareholders’ Meeting
Ceapro Inc. Announces Publication of Positive Results for a PGX Processed Drug Delivery System for Accelerated Burn Wound Healing
Ceapro Inc. to Present at the Virtual Investor Fireside Chat Series
Ceapro Inc. Reports 2020 First Quarter Financial Results and Highlights
Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop Inhalable Therapeutic for COVID-19
Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights
Ceapro Inc. to Present at the April 2020 Virtual Investor Summit
